Literature DB >> 3724244

Polymyositis-dermatomyositis and malignant lesions: does an association exist?

S Lakhanpal, T W Bunch, D M Ilstrup, L J Melton.   

Abstract

To examine the purported association between polymyositis-dermatomyositis and malignant lesions, we identified all patients with histopathologically proven polymyositis-dermatomyositis examined at our institution from 1965 to 1974. For each patient, a control subject was selected, matched for age, sex, race, year and department of clinical evaluation, and geographic area of residence. Although the proportion of patients who ever had a diagnosis of malignant disease (25%) was greater than that for controls (17%), the difference was not statistically significant (P = 0.14). The slight excess of cancer seen among patients was contributed by the most distant referrals and may best be explained on the basis of referral bias. No clinical differences were found between patients with polymyositis-dermatomyositis who had a malignant neoplasm and those who did not, and intensive clinical investigation to exclude "occult" underlying malignant growths did not seem to be cost-effective. Although the present study does not prove that there is no association between polymyositis-dermatomyositis and malignant lesions, the existence of a clinically significant relationship seems unlikely.

Entities:  

Mesh:

Year:  1986        PMID: 3724244     DOI: 10.1016/s0025-6196(12)62030-8

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  27 in total

1.  Localized nodular myositis. A paraneoplastic phenomenon.

Authors:  J E Naschitz; D Yeshurun; U Dreyfuss; L A Best; I Misselevich; J H Boss
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

Review 2.  Polymyositis/dermatomyositis: the current position.

Authors:  A Urbano-Márquez; J Casademont; J M Grau
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

3.  Prognosis and mortality of polymyositis and dermatomyositis patients.

Authors:  A Airio; H Kautiainen; M Hakala
Journal:  Clin Rheumatol       Date:  2006-02-14       Impact factor: 2.980

4.  Low incidence of antinuclear antibodies in dermatomyositis with malignancy.

Authors:  M Nishikai; A Sato
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

5.  When myopathy strikes in a cancer patient.

Authors:  Srivalli Gopaluni; Lilian M Thomas; Chirag Shah
Journal:  Gastrointest Cancer Res       Date:  2009-09

Review 6.  Polymyositis-dermatomyositis: a clinical review.

Authors:  K W Strauss; H Gonzalez-Buritica; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

7.  Dermatomyositis/polymyositis and carcinoma of the ampulla of Vater.

Authors:  G Vayopoulos; C Constantopoulos; C Fotiou; P H Kaklamanis; P H Fessas
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

8.  Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.

Authors:  Rossella Neri; Simone Barsotti; Barsotti Simone; Valentina Iacopetti; Giacomo Iacopetti; Pasquale Pepe; Anna d'Ascanio; Antonio Gaetano Tavoni; Marta Mosca; Stefano Bombardieri
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

9.  Malignancies in Korean patients with inflammatory myopathy.

Authors:  Sang-Won Lee; Sang Youn Jung; Min-Chan Park; Yong-Beom Park; Soo-Kon Lee
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

10.  Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark.

Authors:  W H Chow; G Gridley; L Mellemkjaer; J K McLaughlin; J H Olsen; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1995-01       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.